Literature DB >> 7611296

Correlation between CAG repeat length and clinical features in Machado-Joseph disease.

P Maciel1, C Gaspar, A L DeStefano, I Silveira, P Coutinho, J Radvany, D M Dawson, L Sudarsky, J Guimarães, J E Loureiro.   

Abstract

Machado-Joseph disease (MJD) is associated with the expansion of a CAG trinucleotide repeat in a novel gene on 14q32.1. We confirmed the presence of this expansion in 156 MJD patients from 33 families of different geographic origins: 15 Portuguese Azorean, 2 Brazilian, and 16 North American of Portuguese Azorean descent. Normal chromosomes contain between 12 and 37 CAG repeats in the MJD gene, whereas MJD gene carriers have alleles within the expanded range of 62-84 CAG units. The distribution of expanded alleles and the gap between normal and expanded allele sizes is either inconsistent with a premutation hypothesis or most (if not all) of the alleles we studied descend from a common ancestor. There is a strong correlation between the expanded repeat size and the age at onset of the disease as well as the clinical presentation. There is mild instability of the CAG tract length with transmission of the expanded alleles; both increase and decrease in size between parents and progeny occur, with larger variations in male than in female transmissions. Together, these effects can partly explain the variability of age at onset and of phenotypic features in MJD; however, other modifying factors must exist.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611296      PMCID: PMC1801255     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder.

Authors:  R N Rosenberg; W L Nyhan; C Bay; P Shore
Journal:  Neurology       Date:  1976-08       Impact factor: 9.910

Review 2.  Epidemiology and clinical aspects of Machado-Joseph disease.

Authors:  J Sequeiros; P Coutinho
Journal:  Adv Neurol       Date:  1993

3.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

4.  Joseph disease in a non-Portuguese family.

Authors:  T Sakai; M Ohta; H Ishino
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

5.  Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family.

Authors:  L Lima; P Coutinho
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

6.  Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies.

Authors:  L Sudarsky; L Corwin; D M Dawson
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

7.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.

Authors:  C Lavedan; H Hofmann-Radvanyi; P Shelbourne; J P Rabes; C Duros; D Savoy; I Dehaupas; S Luce; K Johnson; C Junien
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

9.  Type III Machado-Joseph disease in a Japanese family: a clinicopathological study with special reference to the peripheral nervous system.

Authors:  T Kanda; E Isozaki; S Kato; H Tanabe; M Oda
Journal:  Clin Neuropathol       Date:  1989 May-Jun       Impact factor: 1.368

10.  The pathology of Machado-Joseph disease. Report of a possible homozygous case.

Authors:  P Coutinho; A Guimarães; F Scaravilli
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

View more
  69 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 2.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

3.  The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Authors:  H Jacobi; P Bauer; P Giunti; R Labrum; M G Sweeney; P Charles; A Dürr; C Marelli; C Globas; C Linnemann; L Schöls; M Rakowicz; R Rola; E Zdzienicka; T Schmitz-Hübsch; R Fancellu; C Mariotti; C Tomasello; L Baliko; B Melegh; A Filla; C Rinaldi; B P van de Warrenburg; C C P Verstappen; S Szymanski; J Berciano; J Infante; D Timmann; S Boesch; S Hering; C Depondt; M Pandolfo; J-S Kang; S Ratzka; J Schulz; S Tezenas du Montcel; T Klockgether
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

4.  A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease.

Authors:  A L DeStefano; L A Cupples; P Maciel; C Gaspar; J Radvany; D M Dawson; L Sudarsky; L Corwin; P Coutinho; P MacLeod
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

5.  Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1.

Authors:  K Ishikawa; H Tanaka; M Saito; N Ohkoshi; T Fujita; K Yoshizawa; T Ikeuchi; M Watanabe; A Hayashi; Y Takiyama; M Nishizawa; I Nakano; K Matsubayashi; M Miwa; S Shoji; I Kanazawa; S Tsuji; H Mizusawa
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

6.  Mutation detection in Machado-Joseph disease using repeat expansion detection.

Authors:  K Lindblad; A Lunkes; P Maciel; G Stevanin; C Zander; T Klockgether; T Ratzlaff; A Brice; G A Rouleau; T Hudson; G Auburger; M Schalling
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

7.  Different origins of mutations at the Machado-Joseph locus (MJD1)

Authors:  P Iughetti; M Zatz; M R Bueno; S K Marie
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

8.  Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation.

Authors:  L Schöls; G Amoiridis; J T Epplen; M Langkafel; H Przuntek; O Riess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

9.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

10.  Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).

Authors:  Conceição Bettencourt; Raquel Nunes Fialho; Cristina Santos; Rafael Montiel; Jácome Bruges-Armas; Patrícia Maciel; Manuela Lima
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.